NEWS NAVIGATOR
Englemed logo
SIGN UP FOR UPDATES!
Sign up for Englemed updates from TwitterSign up for Englemed updates from Facebook
BOOKS AND GIFTS THIS WAY!
BookshopFor books on women's health, healthy eating ideas, mental health issues, diabetes, etc click here
SEARCH THIS SITE
ENGLEMED
Contact Englemed
Send an e-mail with your comments!
We can provide a specialist, tailored health and medical news service for your site.
Click here for more information
RSS graphic XML Graphic Add to Google
About Englemed news services - services and policies.
Englemed News Blog - Ten years and counting.
Diary of a reluctant allergy sufferer - How the British National Health Service deals with allergy.
Copyright Notice. All reports, text and layout copyright Englemed Ltd, 52 Perry Avenue, Birmingham UK B42 2NE. Co Registered in England No 7053778 Some photos copyright Englemed Ltd, others may be used with permission of copyright owners.
Disclaimer: Englemed is a news service and does not provide health advice. Advice should be taken from a medical professional or appropriate health professional about any course of treatment or therapy.
FreeDigitalPhotos
www.freedigitalphotos.net
FreeWebPhotos
www.freewebphoto.com
TODAY'S NEWS
Day-time abstention may help combat obesity
Fri May 18th - Regular eating times and fasting for a number of hours a day might prove to be beneficial to our health, a US study has claimed. More
Conflict over diet advice for pregnant women
Fri May 18th - Pregnant women can reduce the risk of developing serious complications by following a calorie controlled diet, researchers say today. More
Athlete pain tolerance could aid treatment
Fri May 18th - Athletes’ ability to tolerate pain for longer than non-athletes could give pain management specialists new ways of treating patients, researchers reported yesterday. More
RECENT COMMENTS
On 11/05/2012 Anonymous wrote:
In fact the biggest risk is the patch and the ring - Read more

On 10/05/2012 Editor wrote:
Welcome to Englemed comments. We'd like your view - Read more

THIS WEEK'S STORIES
New heart medicine drive
Thurs May 17th - People with high cholesterol are being encouraged to take their medicines today as research highlighted the benefits of the medicines. More
Nine new breast cancer genes
Thurs May 17th - Nine new genes have been found linked to breast cancer, British scientists revealed last night. More
Poor food tax plan probed
Wed May 16th - Fatty foods would need a "fat tax" of at least 20 per cent to make a significant difference to the way Britons eat, experts warn today. More
Extra time drug u-turn
Wed May 16th - British regulators today performed a u-turn over a controversial drug - which campaigners say can give men with prostate cancer quality "extra time". More
ENGLEMED HEALTH NEWS

Lab-grown tissue ready for liver transplants

Friday January 21st, 2011

Human liver cells grown in a lab could be used in place of donor organs after successful trials.

German researchers used a tissue engineering approach to create new liver tissue, which should provide a potential solution to the obstacles challenging liver cell transplantation.

Dr Joerg-Matthias Pollok, of the Department of Hepatobiliary and Transplantation Surgery at the University Medical Centre in Hamburg, said they grew the cells on resorbable scaffolds made from material similar to surgical sutures.

Liver cell (hepatocyte) transplantation offers a possible solution in overcoming the organ shortage. In addition, liver cells have excellent regenerative potential making liver cell transplantation a viable therapeutic approach for patients with metabolic defects or fulminant hepatic failure as the native liver is preserved while liver dysfunction may resolve as regeneration occurs.

Dr Pollok said isolated liver cells, which can be used for liver cell transplantation, suffer during cell isolation and cryopreservation.

It is one reason why there is limited success with that type of transplant procedure, he said.

Writing in Liver Transplantation, the journal of the American Association for the Study of Liver Diseases, he said: “Our experimental model represents a promising technique to culture human liver cells and prepare them for transplantation on a biodegradable polymer scaffold into the peritoneal cavity.

“Further studies are underway to confirm our results and may ultimately offer viable clinical options for liver cell transplantation in the future.”

A related editorial acknowledges the huge clinical potential for liver cell transplantation.

Dr Humphrey Hodgson, from the UCL Medical School, London, UK, said a number of liver cell transplantation approaches had been used in uncontrolled trials, but effective clinical protocols had not yet been established.

The use of human, rather than rodent, cells by Dr Pollok and team was an important step in advancing the science behind liver cell transplantation, he added.

Primary Human Hepatocytes on Biodegradable PLLA-Matrices: A Promising Model for Improving Transplantation Efficiency Using Tissue Engineering by Eva Török, Marc Lutgehetmann, Jeanette Bierwolf, Stefan Melbeck, Jochen Düllmann, Bjoern Nashan, Peter X. Ma, Joerg M. Pollok. Liver Transplantation; Published Online: October 11, 2010 (DOI: 10.1002/lt.22200); Print Issue Date: February 2011.

Tags: Europe | Internal Medicine | UK News

Printer friendly page Printer friendly page

CATEGORIES